Nathan Rich
Stock Analyst at Goldman Sachs
(1.00)
# 3,907
Out of 5,113 analysts
84
Total ratings
35.48%
Success rate
-10.16%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $14.90 | +40.94% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $122.24 | +60.34% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $11.21 | +167.62% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $12.57 | -36.36% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $22.28 | -21.45% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $259.40 | +48.42% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $22.30 | -37.22% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $30.35 | -63.76% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $157.69 | +42.69% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $700.34 | -7.19% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $77.72 | +13.23% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $20.42 | -41.23% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $77.35 | +9.89% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $11.93 | -7.80% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $163.69 | +104.66% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $327.42 | +63.40% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $14.90
Upside: +40.94%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $122.24
Upside: +60.34%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $11.21
Upside: +167.62%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $12.57
Upside: -36.36%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $22.28
Upside: -21.45%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $259.40
Upside: +48.42%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $22.30
Upside: -37.22%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $30.35
Upside: -63.76%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $157.69
Upside: +42.69%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $700.34
Upside: -7.19%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $77.72
Upside: +13.23%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $20.42
Upside: -41.23%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $77.35
Upside: +9.89%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $11.93
Upside: -7.80%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $163.69
Upside: +104.66%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $327.42
Upside: +63.40%